AXL and head and neck squamous cell carcinoma: In this respect, it must be noted that resistance to BYL719 mediated by Axl occurs through an Akt-independent mTOR activation in HNSCC and ESCC [62]: this would be consistent with our observation that growth and viability of both IC1 and T11 cells are reduced by mTOR inhibition.